WayPoint Biomedical Holdings Inc
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests fo… Read more
Market Cap & Net Worth: WayPoint Biomedical Holdings Inc (WYPH)
WayPoint Biomedical Holdings Inc (PINK:WYPH) has a market capitalization of $5.56K ($5.56K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51221 globally and #15896 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying WayPoint Biomedical Holdings Inc's stock price $0.00 by its total outstanding shares 55602852 (55.60 Million).
WayPoint Biomedical Holdings Inc Market Cap History: 2016 to 2025
WayPoint Biomedical Holdings Inc's market capitalization history from 2016 to 2025. Data shows change from $5.56K to $5.56K (-22.08% CAGR).
WayPoint Biomedical Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how WayPoint Biomedical Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of WYPH by Market Capitalization
Companies near WayPoint Biomedical Holdings Inc in the global market cap rankings as of March 19, 2026.
Key companies related to WayPoint Biomedical Holdings Inc by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
WayPoint Biomedical Holdings Inc Historical Marketcap From 2016 to 2025
Between 2016 and today, WayPoint Biomedical Holdings Inc's market cap moved from $5.56K to $ 5.56K, with a yearly change of -22.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $5.56K | 0.00% |
| 2024 | $5.56K | -50.00% |
| 2023 | $11.12K | -98.89% |
| 2022 | $1.00 Million | -79.75% |
| 2021 | $4.94 Million | +344.50% |
| 2020 | $1.11 Million | +1900.00% |
| 2019 | $55.60K | +900.00% |
| 2018 | $5.56K | 0.00% |
| 2016 | $5.56K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of WayPoint Biomedical Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.56K USD |
| MoneyControl | $5.56K USD |
| MarketWatch | $5.56K USD |
| marketcap.company | $5.56K USD |
| Reuters | $5.56K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.